BRPI0811021A2 - Peptídeos e vacinas de tem8 compreendendo os mesmos - Google Patents

Peptídeos e vacinas de tem8 compreendendo os mesmos

Info

Publication number
BRPI0811021A2
BRPI0811021A2 BRPI0811021-2A2A BRPI0811021A BRPI0811021A2 BR PI0811021 A2 BRPI0811021 A2 BR PI0811021A2 BR PI0811021 A BRPI0811021 A BR PI0811021A BR PI0811021 A2 BRPI0811021 A2 BR PI0811021A2
Authority
BR
Brazil
Prior art keywords
vaccines
peptides
understanding
same
vaccines understanding
Prior art date
Application number
BRPI0811021-2A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Takuya Tsunoda
Ryuji Osawa
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of BRPI0811021A2 publication Critical patent/BRPI0811021A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0811021-2A2A 2007-04-11 2008-04-10 Peptídeos e vacinas de tem8 compreendendo os mesmos BRPI0811021A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91119407P 2007-04-11 2007-04-11
PCT/JP2008/000932 WO2008126413A1 (en) 2007-04-11 2008-04-10 Tem8 peptides and vaccines comprising the same

Publications (1)

Publication Number Publication Date
BRPI0811021A2 true BRPI0811021A2 (pt) 2014-10-21

Family

ID=39863572

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811021-2A2A BRPI0811021A2 (pt) 2007-04-11 2008-04-10 Peptídeos e vacinas de tem8 compreendendo os mesmos

Country Status (12)

Country Link
US (1) US8367799B2 (cg-RX-API-DMAC7.html)
EP (2) EP2508601B1 (cg-RX-API-DMAC7.html)
JP (1) JP5320544B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100016355A (cg-RX-API-DMAC7.html)
CN (2) CN101711280B (cg-RX-API-DMAC7.html)
BR (1) BRPI0811021A2 (cg-RX-API-DMAC7.html)
CA (1) CA2683454A1 (cg-RX-API-DMAC7.html)
IL (2) IL201386A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009010965A (cg-RX-API-DMAC7.html)
RU (2) RU2498993C2 (cg-RX-API-DMAC7.html)
TW (2) TW201425333A (cg-RX-API-DMAC7.html)
WO (1) WO2008126413A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI500932B (zh) * 2008-12-05 2015-09-21 Oncotherapy Science Inc Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
US8574902B2 (en) * 2009-03-05 2013-11-05 Macrocure Ltd. Activated leukocyte composition and uses for wound healing
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
BR112012022641A2 (pt) * 2010-03-11 2017-02-14 Oncotherapy Science Inc peptídeos hjurp e vacinas que incluem os mesmos
KR20130043627A (ko) * 2010-04-09 2013-04-30 온코세라피 사이언스 가부시키가이샤 Cdca5 펩티드 및 이를 포함한 백신
US8557777B2 (en) * 2010-07-09 2013-10-15 The Board Of Trustees Of The University Of Illinois Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides
JP2013537889A (ja) 2010-09-09 2013-10-07 マクロキュア，リミテッド 活性化白血球馴化上清および創傷治癒のための使用
JP6064186B2 (ja) * 2010-12-02 2017-01-25 オンコセラピー・サイエンス株式会社 Ｔｏｍｍ３４ペプチドおよびそれを含むワクチン
AU2012296090B2 (en) * 2011-08-12 2015-05-14 Oncotherapy Science, Inc. MPHOSPH1 peptides and vaccines including the same
SG2014012363A (en) * 2011-10-28 2014-09-26 Oncotherapy Science Inc Topk peptides and vaccines including the same
US20150322112A1 (en) * 2012-12-04 2015-11-12 Oncotherapy Science, Inc. Sema5b peptides and vaccines containing the same
TW201636358A (zh) * 2014-12-09 2016-10-16 腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｇｐｃ３抗原決定位胜肽及含此之疫苗
CN106084026B (zh) * 2016-06-19 2019-10-25 中国人民解放军军事医学科学院生物工程研究所 肿瘤血管内皮细胞标志物8突变体、其融合蛋白及应用
RU2706554C1 (ru) * 2018-12-13 2019-11-19 Российская Федерация, от имени которой выступает ФОНД ПЕРСПЕКТИВНЫХ ИССЛЕДОВАНИЙ Способ создания противоинфекционной иммунологической защиты к Salmonella typhimurium и Listeria monocytogenes с помощью трансгенеза Т-лимфоцитов
KR102873723B1 (ko) * 2025-03-26 2025-10-22 주식회사 포트래이 Antxr1 결합 항체 및 이의 용도

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
CA2225553A1 (en) 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
WO1998004720A1 (en) 1996-07-26 1998-02-05 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6426205B1 (en) * 1997-10-24 2002-07-30 Mount Sinai Hospital Corporation Methods and compositions for modulating ubiquitin dependent proteolysis
WO1999067288A1 (en) 1998-06-25 1999-12-29 Sumitomo Pharmaceuticals Company, Limited Tumor antigen peptides originating in cyclophilin b
US6465717B1 (en) * 1998-11-20 2002-10-15 E. I. Du Pont De Nemours And Company Sterol metabolism enzymes
EP1155117A4 (en) * 1998-12-30 2003-05-14 Millennium Pharm Inc SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING THESE PROTEINS
WO2002010217A2 (en) * 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns
WO2002046228A2 (en) * 2000-12-05 2002-06-13 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US20030092616A1 (en) * 2001-05-25 2003-05-15 Akio Matsuda STAT6 activation gene
US6936707B2 (en) * 2001-07-11 2005-08-30 Zeon Corporation Modified DNA molecule, recombinant containing the same, and uses thereof
WO2003080647A2 (en) * 2002-03-19 2003-10-02 Monsanto Technology, Llc Homogentisate prenyl transferase ('hpt') nucleic acids and polypeptides, and uses thereof
US7160994B2 (en) * 2002-03-28 2007-01-09 Trustees Of The University Of Pennsylvania Osteoclast-specific genes and proteins and uses thereof
CN103073620B (zh) 2002-09-12 2014-12-10 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
JP2007511534A (ja) * 2003-11-13 2007-05-10 スローン−ケッタリング インスティトゥート フォー カンサー リサーチ 抗腫瘍免疫の相乗的誘導のための組成物および方法
JP4628208B2 (ja) * 2004-08-10 2011-02-09 オンコセラピー・サイエンス株式会社 Ｃｘａｄｒｌ１またはｇｃｕｄ１タンパク質を発現する胃癌または結腸直腸癌の治療のためのペプチドワクチン
CA2580412A1 (en) 2004-09-13 2006-03-23 Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services Compositions comprising t cell receptors and methods of use thereof
KR101130597B1 (ko) 2005-09-13 2012-04-02 다카라 바이오 가부시키가이샤 Ｔ 세포 리셉터 및 그 리셉터를 코드하는 핵산
ITRM20060337A1 (it) * 2006-06-27 2007-12-28 Biosoot Srl Gene tem8 (tumor endotelial marker 8) e sue forme di espressione ed usi diagnostici e terapeutici

Also Published As

Publication number Publication date
TWI434853B (zh) 2014-04-21
US20120093843A1 (en) 2012-04-19
RU2009141595A (ru) 2011-05-20
CA2683454A1 (en) 2008-10-23
HK1175197A1 (en) 2013-06-28
JP2010523471A (ja) 2010-07-15
US8367799B2 (en) 2013-02-05
AU2008238739A1 (en) 2008-10-23
KR20100016355A (ko) 2010-02-12
TW201425333A (zh) 2014-07-01
EP2508601B1 (en) 2014-11-05
EP2155872A1 (en) 2010-02-24
TW200906850A (en) 2009-02-16
EP2508601A2 (en) 2012-10-10
WO2008126413A1 (en) 2008-10-23
IL201386A0 (en) 2011-08-01
EP2508601A3 (en) 2013-02-13
CN101711280A (zh) 2010-05-19
RU2013131089A (ru) 2015-01-10
RU2498993C2 (ru) 2013-11-20
CN102786582A (zh) 2012-11-21
CN102786582B (zh) 2014-06-11
EP2155872A4 (en) 2010-04-28
IL220752A0 (en) 2012-08-30
JP5320544B2 (ja) 2013-10-23
MX2009010965A (es) 2009-12-01
CN101711280B (zh) 2013-04-10

Similar Documents

Publication Publication Date Title
BRPI0811021A2 (pt) Peptídeos e vacinas de tem8 compreendendo os mesmos
NL301192I2 (nl) Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
BRPI0815380A2 (pt) Dispositivo de emissão de luz e dispositivo de iluminação compreendendo o mesmo
DK2222706T3 (da) Antibodies against human nkg2d and uses thereof
DK1968631T3 (da) Vaccine
EP2175817A4 (en) ABSORBENT ARTICLE ADHERING TO THE BODY
DE602008002748D1 (de) Linseneinführsystem
DK1957528T3 (da) Nukleotid-vaccine
BRPI0815578A2 (pt) Peptídeo de cdca1 e agente farmacêutico compreendendo o mesmo.
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
BRPI0812015A2 (pt) Membro de reforço de borracha e produto de borracha utilizando o mesmo.
BRPI0917391A2 (pt) peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo
BRPI0913436A2 (pt) peptídeos de ep´topo de mybl2 e vacinas contendo oso mesmos
DE502007005032D1 (de) Der Astromischer
PL1921210T3 (pl) Element zabezpieczający przed lawiną i tym podobnymi
EP2189548A4 (en) SPANNUNGSPUFFERUNGSMATERIAL
BRPI0717223A2 (pt) polipeptÍdeos hÍbridos imunogÊnicos antiobesidade e composiÇço de vacina antiobesidade compreendendo os mesmos
BRPI1010666A2 (pt) peptídeos de cdc45l e vacinas incluindo dos mesmos
BRPI0919766A2 (pt) peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
BRPI0923402A2 (pt) Peptídeos c10rf59 e vacinas incluindo os mesmos.
BRPI1012312A2 (pt) peptídeos vangl1 e vacinas incluindo os mesmos
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
SE0600005L (sv) Värmare

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]